stock.name

Nektar Therapeutics

NKTR

Market Cap$164.76M
Close$

Compare Nektar Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nektar TherapeuticsNektar Therapeutics-0.60%-211%--
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9

Share Statistics

Market cap$164.76 Million
Enterprise Value$-138,855,733.00
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.45
Beta2.69
Outstanding Shares183,617,817
Avg 30 Day Volume2,558,216

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-0.6
PEG2.02
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-1.54
Enterprise Value to EBIT1.03
Enterprise Value to Net Income0
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Nektar Therapeutics

CEO: Howard Robin